2Samrao D, Wang D, Ough F, et al. Histologic parameters predictive of disease outcome in women with advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy[J]. Transl Oncol, 2012, 5(6):469-474.
3Rooth C. Ovarian cancer: risk factors, treatment and management[J]. Br J Nurs, 2013, 22(17):$23-30. DOI: 10.12968/bjon.2013.22.Sup 17.S23.
4Lu Y, Liu P, Wen W, et al. Cross-species comparison of orthologous gene expression in human bladder cancer and carcinogen-induced rodent models[J]. Am J Transl Res, 2010, 3(1):8-27.
5Hsu PI, Chen CH, Hsiao M, et al. Diagnosis of gastric malignancy using gastric juice alphal-antitrypsin[J]. Cancer Epidemiol Biomarkers Prey, 2010, 19(2):405-411. DOI: 10.1158/1055-9965.EPI-09-0609.
6E1-Akawi Z J, Abu-Awad AM, Sharara AM, et al. The importance of alpha-1 antitrypsin (alphal-AT) and neopterin serum levels in the evaluation of non-small cell lung and prostate cancer patients[J]. Neuro Endocrinol Lett, 2010, 31(1):113-116.
7Qin X, Chert Q, Sun C, et al. High-throughput screening of tumor metastatic-related differential glycoprotein in hepatocellular carcinoma by iTRAQ combines lectin-related techniques[J]. Med Oncol, 2013, 30(1):420. DOI: 10.1007/ s 12032-012-0420-8.
8Normandin K, P6ant B, Le PC, et al. Protease inhibitor SERPINA1 expression in epithelial ovarian cancer[J]. Clin Exp Metastasis, 2010, 27(1):55-69. DOI: 10.1007/s10585-009-9303-6.
9Mutlu P, Ural AU, Gtindtiz U. Differential gene expression analysis related to extracellular matrix components in drug-resistant RPMI-8226 cell line[J]. Biomed Pharmacother, 2012, 66(3):228-231. DOI: 10.1016/j.biopha.2011.11.023.
10Lou X, Han X, Jin C, et al. SOX2 targets fibronectin 1 to promote cell migration and invasion in ovarian cancer: new molecular leads for therapeutic intervention[J]. OMICS, 2013, 17(10):510-518. DOI: 10.1089/omi.2013.0058.
